Rossari Biotech (NSE:ROSSARI) Beta: 1.8616 (As of Jun. 26, 2026)


NSE:ROSSARI Rossari Biotech Ltd NSE:ROSSARI
85 GF Score
Price ₹534.85
GF Value ₹998.23
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Rossari Biotech Beta?

Rossari Biotech NSE:ROSSARI -0.48% 85 Beta is 1.8616 as of Jun. 26, 2026. GuruFocus rates NSE:ROSSARI with a GF Score™ of 85/100 and a GF Value™ of ₹998.23 (Possible Value Trap). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Rossari Biotech's Beta is 1.8616.


Rossari Biotech  (NSE:ROSSARI) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Rossari Biotech Beta Related Terms


Rossari Biotech Beta Historical Data

* Premium members only.

The historical data trend for Rossari Biotech's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rossari Biotech Beta Chart

Rossari Biotech Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.84 1.24 1.85

Rossari Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 1.44 1.58 1.88 1.85

NSE:ROSSARI vs LIN, SHW, ECL: Beta Comparison

For the Specialty Chemicals subindustry, Rossari Biotech's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rossari Biotech Beta vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Rossari Biotech's Beta distribution charts can be found below:

* The bar in red indicates where Rossari Biotech's Beta falls into.


NSE:ROSSARI
85GF Score
Rossari Biotech Ltd NSE:ROSSARI
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rossari Biotech Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.8616 mean?
Rossari Biotech (NSE:ROSSARI) has a Beta of 1.8616 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Rossari Biotech and its competitors.
Is Rossari Biotech's Beta too high?
Rossari Biotech's current Beta is 1.8616. Overall, Rossari Biotech has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Beta compare to LIN and SHW?
Rossari Biotech's Beta of 1.8616 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Chemicals company?
A good Beta depends on the Chemicals industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Rossari Biotech and its competitors. Rossari Biotech's current Beta is 1.8616. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹998.23, compared to a current price of ₹534.85 — trading 46.4% below its estimated fair value. The current Beta is 1.8616. Rossari Biotech's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Beta is 1.8616 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?

Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued. The current stock price of ₹534.85 is trading 46.4% below its estimated GF Value™ of ₹998.23. GuruFocus considers Rossari Biotech to be Possible Value Trap.

Key valuation signals for NSE:ROSSARI:

  • Beta: 1.8616
  • GF Value™: ₹998.23 vs. price of ₹534.85 (46.4% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rossari Biotech Business Description

Other Exchanges 543213:India
Address Rossari House, Lal Bahadur Shastri Marg, Golden Oak, Opp. Mahindra Showroom, Vikhroli (West), Surya Nagar, Mumbai, MH, IND, 400079
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
85GF Score

Get the complete analysis for NSE:ROSSARI

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹534.85
Price
₹998.23
GF Value